Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for ... with four approved products: Qletli and Betagrin in China, and Tofidence ...

Intas Pharma becomes most valuable privately held pharma company A PE deal values Intas at Rs 23,000 crore or USD 3.5 billion, making it the most valued pharma privately held company in India.

In a warning letter to the company's CEO and MD Nimish Chudgar, the US Food and Drug Administration (USFDA) has pointed out various manufacturing lapses at the Matoda-Sanand, Ahmedabad-based facility.